drugset / Trial / NCT03000595
A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Withdrawn
Santalis Pharmaceuticals, Inc.
ClinDatrix, Inc. · collabFremantle Dermatology · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and efficacy trial of SAN007 (5% East Indian sandalwood oil in a cream formulation) treatment regimen when administered daily for up to 28 days to patients from 3 months to 65 years of age, with atopic dermatitis.
Timeline
- Start
- 2018-06
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Essential oils | Unknown | 5 % | Topical |